SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nabeen C. Nayak, Cirrhosis and end-stage chronic liver disease: The changing scenes on etiopathogenesis, Current Medicine Research and Practice, 2014, 4, 2, 62

    CrossRef

  2. 2
    Yongli Hua, Wenxin Xue, Man Zhang, Yanming Wei, Peng Ji, Metabonomics study on the hepatoprotective effect of polysaccharides from different preparations of Angelica sinensis, Journal of Ethnopharmacology, 2014, 151, 3, 1090

    CrossRef

  3. 3
    Ying Jiang, Chi Wang, Ying-Ying Li, Xue-Cong Wang, Jian-Duo An, Yun-Jiao Wang, Xue-Jiang Wang, Mistletoe alkaloid fractions alleviates carbon tetrachloride-induced liver fibrosis through inhibition of hepatic stellate cell activation via TGF-β/Smad interference, Journal of Ethnopharmacology, 2014, 158, 230

    CrossRef

  4. 4
    Chao Guo, Lingyuan Xu, Qiaoling He, Tao Liang, Xiaoqun Duan, Rong Li, Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway, Food and Chemical Toxicology, 2013, 56, 436

    CrossRef

  5. 5
    Hui Zhang, Yan Guan, Yi-Yu Lu, Yi-Yang Hu, Shuang Huang, Shi-Bing Su, Circulating miR-583 and miR-663 Refer to ZHENG Differentiation in Chronic Hepatitis B, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1

    CrossRef

  6. 6
    Qing-Ya Li, Zhi-Zhong Guo, Xin Deng, Lie-Ming Xu, Yue-Qiu Gao, Wei Zhang, Xiao-Su Wang, Dong-Ying Xue, Yi-Yu Lu, Ping Liu, Shi-Bing Su, Curative Effects of ZHENG-Based Fuzheng-Huayu Tablet on Hepatitis B Caused Cirrhosis Related to CYP1A2 Genetic Polymorphism, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1

    CrossRef

  7. 7
    Quanfang Huang, Shijun Zhang, Renbin Huang, Ling Wei, Yongxing Chen, Shujuan Lv, Chunhong Liang, Shimei Tan, Shuang liang, Lang Zhuo, Xing Lin, Isolation and identification of an anti-hepatitis B virus compound from Hydrocotyle sibthorpioides Lam, Journal of Ethnopharmacology, 2013, 150, 2, 568

    CrossRef

  8. 8
    Yi Tan, Weiguo Lao, Linda Xiao, Zhenzhong Wang, Wei Xiao, Mohamed A. Kamal, J. Paul Seale, Xianqin Qu, Managing the Combination of Nonalcoholic Fatty Liver Disease and Metabolic Syndrome with Chinese Herbal Extracts in High-Fat-Diet Fed Rats, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1

    CrossRef

  9. 9
    Rui Jia, Liping Cao, Jinliang Du, Pao Xu, Galina Jeney, Guojun Yin, The protective effect of silymarin on the carbon tetrachloride (CCl4)-induced liver injury in common carp (Cyprinus carpio), In Vitro Cellular & Developmental Biology - Animal, 2013, 49, 3, 155

    CrossRef

  10. 10
    Don C. Rockey, Translating an Understanding of the Pathogenesis of Hepatic Fibrosis to Novel Therapies, Clinical Gastroenterology and Hepatology, 2013, 11, 3, 224

    CrossRef

  11. 11
    Ya-Nan Song, Hui Zhang, Yan Guan, Jing-Hua Peng, Yi-Yu Lu, Yi-Yang Hu, Shi-Bing Su, Classification of Traditional Chinese Medicine Syndromes in Patients with Chronic Hepatitis B by SELDI-Based ProteinChip Analysis, Evidence-Based Complementary and Alternative Medicine, 2012, 2012, 1

    CrossRef

  12. 12
    Jing Li, Peng Liu, Ruixiu Zhang, Lu Cao, Haihua Qian, Jian Liao, Wen Xu, Mengchao Wu, Zhengfeng Yin, Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats, Journal of Ethnopharmacology, 2011, 137, 1, 714

    CrossRef

  13. 13
    Yu-Ping Wang, Wei Zhao, Rong Xue, Zhen-Xian Zhou, Fei Liu, Yan-Xing Han, Gang Ren, Zong-Gen Peng, Shan Cen, Hong-Shan Chen, Yu-Huan Li, Jian-Dong Jiang, Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance, Antiviral Research, 2011, 89, 3, 227

    CrossRef

  14. 14
    Na-Na Du, Xin Li, Yu-Ping Wang, Fei Liu, Yan-Xin Liu, Chun-Xin Li, Zong-Gen Peng, Li-Mei Gao, Jian-Dong Jiang, Dan-Qing Song, Synthesis, structure−activity relationship and biological evaluation of novel N-substituted matrinic acid derivatives as host heat-stress cognate 70 (Hsc70) down-regulators, Bioorganic & Medicinal Chemistry Letters, 2011, 21, 16, 4732

    CrossRef

  15. 15
    Xiao-Xi Zeng, Zhao-Xiang Bian, Tai-Xiang Wu, Shu-Fei Fu, Eric Ziea, Wong Taam Chi Woon, Traditional Chinese Medicine Syndrome Distribution in Chronic Hepatitis B Populations: A Systematic Review, The American Journal of Chinese Medicine, 2011, 39, 06, 1061

    CrossRef

  16. 16
    Changhai Sun, Yang Teng, Guangzhi Li, Saburo Yoshioka, Junko Yokota, Mitsuhiko Miyamura, Hongzhuang Fang, Yu Zhang, Metabonomics study of the protective effects of Lonicera japonica extract on acute liver injury in dimethylnitrosamine treated rats, Journal of Pharmaceutical and Biomedical Analysis, 2010, 53, 1, 98

    CrossRef

  17. 17
    Peng-Fei Yue, Hai-Long Yuan, Xian-Yi Li, Ming Yang, Wei-Feng Zhu, Process optimization, characterization and evaluation in vivo of oxymatrine–phospholipid complex, International Journal of Pharmaceutics, 2010, 387, 1-2, 139

    CrossRef

  18. 18
    Yang Teng, Chang Hai Sun, Guangzhi Li, Guangchen Sun, Yui Nomachi, Junko Yokota, Saburo Yoshioka, Jinbo Gang, Shuqing Jiao, Yu Zhang, Mitsuhiko Miyamura, Protective effects of Flos lonicera extract on acute liver injury by dimethylnitrosamine-induced in rats, Journal of Natural Medicines, 2010, 64, 3, 288

    CrossRef

  19. 19
    Jing-Zheng Song, Chun-Feng Qiao, Song-Lin Li, Yan Zhou, Ming-Tsuen Hsieh, Hong-Xi Xu, Rapid optimization of dual-mode gradient high performance liquid chromatographic separation of Radix et Rhizoma Salviae Miltiorrhizae by response surface methodology, Journal of Chromatography A, 2009, 1216, 42, 7007

    CrossRef

  20. 20
    Don C. Rockey, Current and Future Anti-Fibrotic Therapies for Chronic Liver Disease, Clinics in Liver Disease, 2008, 12, 4, 939

    CrossRef

  21. 21
    Arvind S. Negi, J.K. Kumar, Suaib Luqman, Karuna Shanker, M.M. Gupta, S.P.S. Khanuja, Recent advances in plant hepatoprotectives: A chemical and biological profile of some important leads, Medicinal Research Reviews, 2008, 28, 5
  22. 22
    Sumita Verma, Paul J. Thuluvath, Complementary and Alternative Medicine in Hepatology: Review of the Evidence of Efficacy, Clinical Gastroenterology and Hepatology, 2007, 5, 4, 408

    CrossRef

  23. 23
    Crystal Sao-Fong Cheung, Karen Ka-Wing Chung, Julian Chun-Kin Lui, Ching-Po Lau, Po-Ming Hon, Judy Yuet-Wa Chan, Kwok-Pui Fung, Shannon Wing-Ngor Au, Leachianone A as a potential anti-cancer drug by induction of apoptosis in human hepatoma HepG2 cells, Cancer Letters, 2007, 253, 2, 224

    CrossRef

  24. 24
    R. Harish, T. Shivanandappa, Antioxidant activity and hepatoprotective potential of Phyllanthus niruri, Food Chemistry, 2006, 95, 2, 180

    CrossRef

  25. 25
    Shi-Jun Zhang, Ze-Xiong Chen, Kai-Ping Jiang, Wei-Kang Wu, Cui-Yi Zhang, Yan-Li Gu, Effect of seasonal variation on the clinical course of chronic hepatitis B, Journal of Gastroenterology, 2006, 41, 11, 1107

    CrossRef

  26. 26
    K. T. Leung, Lawrence C. M. Chiu, W. S. Lam, Yaolan Li, Samuel S. M. Sun, Vincent E. C. Ooi, In vitro antiviral activities of Chinese medicinal herbs against duck hepatitis B virus, Phytotherapy Research, 2006, 20, 10
  27. 27
    G. Bagalkotkar, S. R. Sagineedu, M. S. Saad, J. Stanslas, Phytochemicals from Phyllanthus niruri Linn. and their pharmacological properties: a review, Journal of Pharmacy and Pharmacology, 2006, 58, 12
  28. 28
    Lindsay Mollison, Leanne Totten, James Flexman, Miles Beaman, Robert Batey, Randomized double blind placebo-controlled trial of a Chinese herbal therapy (CH100) in chronic hepatitis C, Journal of Gastroenterology and Hepatology, 2006, 21, 7
  29. 29
    Don C. Rockey, Antifibrotic therapy in chronic liver disease, Clinical Gastroenterology and Hepatology, 2005, 3, 2, 95

    CrossRef

  30. 30
    Robert G. Batey, Ses J. Salmond, Alan Bensoussan, Complementary and alternative medicine in the treatment of chronic liver disease, Current Gastroenterology Reports, 2005, 7, 1, 63

    CrossRef

  31. 31
    Marta R. Romero, Thomas Efferth, Maria A. Serrano, Beatriz Castaño, Rocio I.R. Macias, Oscar Briz, Jose J.G. Marin, Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an “in vitro” replicative system, Antiviral Research, 2005, 68, 2, 75

    CrossRef

  32. 32
    Yihuai Gao, He Gao, Eli Chan, Wenbo Tang, Xiaotian Li, Jun Liang, Shufeng Zhou, Protective Effect ofGanoderma(a Mushroom with Medicinal Properties) Against Various Liver Injuries, Food Reviews International, 2005, 21, 1, 27

    CrossRef

  33. 33
    Soon Yew Tang, Matthew Whiteman, Zhao Feng Peng, Andrew Jenner, Eu Leong Yong, Barry Halliwell, Characterization of antioxidant and antiglycation properties and isolation of active ingredients from traditional chinese medicines, Free Radical Biology and Medicine, 2004, 36, 12, 1575

    CrossRef

  34. 34
    James R. Jacob, Brent E. Korba, Jung Eun You, Bud C. Tennant, Young-Ho Kim, Korean Medicinal Plant Extracts Exhibit Antiviral Potency Against Viral Hepatitis, The Journal of Alternative and Complementary Medicine, 2004, 10, 6, 1019

    CrossRef

  35. 35
    James R. Jacob, Brent E. Korba, Jung Eun You, Bud C. Tennant, Young-Ho Kim, Korean Medicinal Plant Extracts Exhibit Antiviral Potency Against Viral Hepatitis, Journal of Alternative and Complementary Medicine, 2004, 10 , 6, 1019

    CrossRef

  36. 36
    Cândida A.L Kassuya, Aline A Silvestre, Vera Lúcia G Rehder, João B Calixto, Anti-allodynic and anti-oedematogenic properties of the extract and lignans from Phyllanthus amarus in models of persistent inflammatory and neuropathic pain, European Journal of Pharmacology, 2003, 478, 2-3, 145

    CrossRef

  37. 37
    YUN-FAN LIAW, NANCY LEUNG, RICHARD GUAN, GEORGE KK LAU, ISMAIL MERICAN, Asian-Pacific consensus statement on the management of chronic hepatitis B: An update, Journal of Gastroenterology and Hepatology, 2003, 18, 3
  38. 38
    Alexandra K Kiemer, Thomas Hartung, Christian Huber, Angelika M Vollmar, Phyllanthus amarus has anti-inflammatory potential by inhibition of iNOS, COX-2, and cytokines via the NF-κB pathway, Journal of Hepatology, 2003, 38, 3, 289

    CrossRef

  39. 39
    YUHONG DONG, HONGLI Xi, YANYAN YU, QINHUAN Wang, KAN JIANG, LIUZHE LI, Effects of oxymatrine on the serum levels of T helper cell 1 and 2 cytokines and the expression of the S gene in hepatitis B virus S gene transgenic mice: A study on the anti-hepatitis B virus mechanism of oxymatrine, Journal of Gastroenterology and Hepatology, 2002, 17, 12
  40. 40
    Seon-Hee Oh, Ji-Xing Nan, Dong-Hwan Sohn, Youn-Chul Kim, Byung-Hoon Lee, Salvia miltiorrhiza Inhibits Biliary Obstruction-Induced Hepatocyte Apoptosis by Cytoplasmic Sequestration of p53, Toxicology and Applied Pharmacology, 2002, 182, 1, 27

    CrossRef

  41. 41
    George K.K. Lau, HEPATITIS B INFECTION IN CHINA, Clinics in Liver Disease, 2001, 5, 2, 361

    CrossRef

  42. 42
    Consensus statements on the prevention and management of hepatitis B and hepatitis C in the Asia–Pacific region1, Journal of Gastroenterology and Hepatology, 2000, 15, 8
  43. 43
    Jian Ping Liu, Heather McIntosh, Hui Lin, Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection, The Cochrane Library,
  44. 44
    Jian Ping Liu, Heather McIntosh, Hui Lin, Chinese medicinal herbs for chronic hepatitis B, The Cochrane Library,
  45. 45
    Jian Ping Liu, Hui Lin, Christian Gluud, Comparison of medicinal herbs for chronic hepatitis B virus infection, The Cochrane Library,
  46. 46
    Jian Ping Liu, Eric Manheimer, Kiichiro Tsutani, Christian Gluud, Medicinal herbs for hepatitis C virus infection, The Cochrane Library,